Overview
Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.
Description
Long-term mortality after transcatheter mitral or tricuspid valve therapy
Eligibility
Inclusion Criteria:
- Age above 18 years and consentable
- Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
- Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
- Written informed consent
Exclusion Criteria:
- Patient's inability to fully cooperate with the protocol